Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific …